Profile

Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting TLR4, in order to address the immune failure underpinning cancers. PPI-100 activates dendritic cells and macrophages, increasing antigen-presenting activities directed at tumor antigens and resulting in anti-cancer cytotoxic T-cells and long-term T-cell memory. PPI-100 is being developed in the perioperative setting to address the >40% relapse rate in cancer patients 5 years following surgery, and works with MD Anderson, Massachusetts General Hospital and others.

Event details

Date: January 8 - 10, 2024

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

18 in total
  • Allarta Life Science
    Allarta Life Science is a pre-clinical life science platform company developing next-generation biomaterials for…
  • Canurta
    Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from…
  • Enhanced Medical Nutrition (EMN)
    Enhanced Medical Nutrition (EMN) is a life sciences company that develops medical food products to…
  • GL CHEMTEC International
    For more than 20 years, GL CHEMTEC International (“GLC”) has been a leading chemistry-…
  • HDAX Therapeutics
    HDAX Therapeutics is pioneering best-in-class therapeutics for neurological and cardiovascular diseases.…
  • ImmunoBiochem Corporation
    ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel biological therapeutics to…
  • Iseehear Inc. Life Sciences
    Iseehear Inc. pioneers transformative data management solutions for the Life Sciences community. It optimizes…
  • Mannin Research
    Mannin Research stands at the forefront of innovation, driving the development of the groundbreaking Ang1-C4bp…
  • Mediphage
    Mediphage has developed a proprietary and scalable E. coli-based manufacturing process for the production of…
  • Nucro-Technics
    Nucro-Technics is a full-service contract support organization that specializes in the conduct of both GLP…
  • panCELLa Inc.
    panCELLa is focused on engineering cells with total control to provide safe and effective cells in an economically…
  • Pattern Pharma
    Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting…
  • PolyAnalytik, Inc.
    PolyAnalytik is a contract research organization that specializes in the analysis and purification of medical…
  • PurMinds NeuroPharma
    PurMinds is a neuro-medicine development and API supply company focused on the treatment of neurological…
  • QurCan Therapeutics Inc.
    QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and…
  • Rna Diagnostics
    The need for tools to optimize treatment based on a patient's personal response to treatment is critical for the…
  • Specific Biologics Inc.
    At Specific Biologics, its mission is to develop therapeutics to treat or cure disease through precision gene editing…
  • Spiderwort Inc.
    Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number of…